Can a Doctor's eye and a quick slide test diagnose lung fluid cancer in real time?

NCT ID NCT07286045

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at two ways to quickly tell if fluid around the lungs (pleural effusion) is cancerous during a procedure called thoracoscopy. Doctors visually inspected the lining of the lung and also did a rapid test on biopsy samples right in the procedure room. The goal was to see if these methods could give an accurate diagnosis faster than waiting for standard lab results. The study involved 33 adults with undiagnosed pleural effusion.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors diagnose pleural effusion faster and more accurately during thoracoscopy, potentially reducing the need for repeat procedures.
What could go wrong
This is a small, completed observational study with only 33 participants. The methods may not be accurate enough to replace standard lab testing, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

33 people

The number who actually took part.

Started

Dec 2023

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients (\>18 years) with undiagnosed exudative pleural effusion undergoing medical thoracoscopy.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria included adult patients (\>18 years) with undiagnosed pleural effusion undergoing medical thoracoscopy. Exclusion Criteria: Exclusion Criteria, while Medical thoracoscopy is generally safe; patients with the following conditions were excluded in accordance with reported contraindications (Jin et al., 2020): 1. Absolute contraindications: * Refusal to participate in the study. * Extensive pleural adhesions (e.g., pleural fibrosis, post-infection, or prior pleurodesis). * Inadequate pleural space for thoracoscopy. 2. Relative contraindications\*\* * Coagulopathy (platelet count \<60 × 10⁹/L or INR \>1.2), unless corrected prior to the procedure. The use of aspirin and clopidogrel was not considered a contraindication. * Inability to tolerate the lateral decubitus position. * Unstable hemodynamic status. * Severe hypoxemia requiring high-flow oxygen therapy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pleural effusion disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pleural disorder Pleural Effusion

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ain shams university

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.